A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
The Journal of Dermatology · 2024
DOI: 10.1111/1346-8138.17381 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Anwar Al Hammadi und 8 weiteren Autor:innen. Beteiligte Einrichtung: DermaMed Clinic, Dubai, UAE. Hauptthemen laut MEDLINE: Alopecia Areata, Comorbidity, Databases, Factual, Cost of Illness. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Alopecia areata (AA) is an autoimmune disorder that manifests as nonscarring hair loss and imposes a substantial disease burden. The current study, using an e‐claims database, assesses the disease burden, comorbidities, treatment patterns, specialties involved in the diagnosis of AA, healthcare resource utilization (HCRU), and associated costs in privately insured patients with AA in Dubai, United Arab Emirates. The retrospective longitudinal secondary study was conducted using Dubai Real‐World Database e‐claims data during 01 January 2014 to 30 June 2022. Patients with at least one diagnosis claim of AA during the index period (01 January 2015–30 June 2021) with continuous enrollment (one or more AA/non‐AA claim in the post‐index period) were included in the analysis. The patients were stratified into subcohorts based on diagnosis code and treatment patterns, as mild, moderate‐to‐severe , and others. Demographics, comorbidities, treatment patterns, specialists visited, and HCRU were assessed. The study included 11 851 patients with AA (mean age: mild: 37 years; moderate‐to‐severe : 36 years), with a male predominance (mild: 77.6%; moderate‐to‐severe : 60.8%). The most prevalent comorbidities in the moderate‐to‐severe AA subcohort were autoimmune and T‐helper 2–mediated immune disorders, including contact dermatitis and eczema (62.1%), atopic dermatitis (36.1%), and asthma (36.1%). Most patients consulted dermatologists for treatment advice (mild AA: 87.4%; moderate‐to‐severe AA: 47.7%) and, notably, within 1 day of AA diagnosis. Topical steroids were frequently prescribed across cohorts, regardless of disease severity. Analysis of comorbidities among patients with AA indicated an additional HCRU burden among these subsets of patients. The median disease‐specific HCRU cost was higher for psychological comorbidities versus autoimmune and T‐helper 2–mediated immune disorders (US $224.99 vs US $103.70). There is a substantial disease and economic burden in patients with AA and associated comorbid conditions; therefore, investing in novel therapies that target the underlying autoimmune pathway may address the gap in effective management of AA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DermaMed Clinic, Dubai, UAE.
- Dubai Health Authority, Dubai, UAE.
- Pfizer Inc. Ltd, Dubai, UAE.
- EMEA Consulting Services, IQVIA, Bengaluru, India.
- Real-World Evidence, IQVIA, Dubai, UAE.
ORCID-Profile: Nisha V Parmar, Badarinath Chickballapur Ramachandrachar, Haytham Mohamed Ahmed
Zitieren
APA
Hammadi, A. A., Parmar, N. V., Farghaly, M., Dallal, S. A., Zayed, M. W. A., Ebeid, F., Subramanyam, K., Ramachandrachar, B. C., & Ahmed, H. M. (2024). A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17381
Vancouver
Hammadi AA, Parmar NV, Farghaly M, Dallal SA, Zayed MWA, Ebeid F, et al. A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17381
BibTeX
@article{Hammadi2024,
author = {Hammadi, Anwar Al and Parmar, Nisha V and Farghaly, Mohamed and Dallal, Sara Al and Zayed, Mostafa Wagdy Abdullah and Ebeid, Fadwa and Subramanyam, Kumaresan and Ramachandrachar, Badarinath Chickballapur and Ahmed, Haytham Mohamed},
title = {A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database},
journal = {The Journal of Dermatology},
year = {2024},
doi = {10.1111/1346-8138.17381}
}
EUVIMED